About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- quetiapine
- Procedure number
- PSUSA/00002589/202307
- Regulatory outcome
- Variation
Documents
Quetiapine : List of nationally authorised medicinal products - PSUSA/00002589/202307
English (EN) (654.36 KB - PDF)
Quetiapine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002589/202307
English (EN) (175.47 KB - PDF)
български (BG) (210.83 KB - PDF)
español (ES) (179.11 KB - PDF)
čeština (CS) (242.71 KB - PDF)
dansk (DA) (176.96 KB - PDF)
Deutsch (DE) (194.22 KB - PDF)
eesti keel (ET) (168.84 KB - PDF)
ελληνικά (EL) (222.71 KB - PDF)
français (FR) (198.59 KB - PDF)
hrvatski (HR) (241.71 KB - PDF)
íslenska (IS) (181.69 KB - PDF)
Gaeilge (GA) (176.73 KB - PDF)
italiano (IT) (176.46 KB - PDF)
latviešu valoda (LV) (248.49 KB - PDF)
lietuvių kalba (LT) (229.06 KB - PDF)
magyar (HU) (256.39 KB - PDF)
Malti (MT) (248.18 KB - PDF)
Nederlands (NL) (182.91 KB - PDF)
norsk (NO) (191.44 KB - PDF)
polski (PL) (236.28 KB - PDF)
português (PT) (182.14 KB - PDF)
română (RO) (221.81 KB - PDF)
slovenčina (SK) (245.72 KB - PDF)
slovenščina (SL) (227.51 KB - PDF)
Suomi (FI) (172.85 KB - PDF)
svenska (SV) (178.89 KB - PDF)